As of 2026-10-05, the Intrinsic Value of Immunic Inc (IMUX) is -38.28 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.96 USD, the upside of Immunic Inc is -580.96%.
Based on its market price of 7.96 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 580.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -38.28 - -38.28 | -38.28 | -580.96% |
| P/E | (9.04) - (33.84) | (21.44) | -369.3% |
| DDM - Stable | (43.43) - (105.04) | (74.24) | -1032.6% |
| DDM - Multi | (1.79) - (3.36) | (2.33) | -129.3% |
| Market Cap (mil) | 108.42 |
| Beta | 0.24 |
| Outstanding shares (mil) | 13.62 |
| Enterprise Value (mil) | -78.21 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.45% |
| Cost of Debt | 5.00% |
| WACC | 8.56% |